Cargando…
High rates of early treatment discontinuation in hepatitis C-infected US veterans
BACKGROUND: Patients with chronic hepatitis C (HCV) frequently discontinued dual therapy with pegylated interferon alfa (Peg-IFN) plus ribavirin (RBV) before reaching the recommended duration of 48 or 24 weeks for genotypes (G) 1/4 or 2/3, respectively. We quantified rates of discontinuation despite...
Autores principales: | LaFleur, Joanne, Hoop, Robert, Morgan, Timothy, DuVall, Scott L, Pandya, Prashant, Korner, Eli, Knippenberg, Kristin, Hayden, Candace, Nelson, Richard E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012175/ https://www.ncbi.nlm.nih.gov/pubmed/24758162 http://dx.doi.org/10.1186/1756-0500-7-266 |
Ejemplares similares
-
Determining Multiple Sclerosis Phenotype from Electronic Medical Records
por: Nelson, Richard E., et al.
Publicado: (2016) -
Health Care Costs in a Cohort of HIV-Infected U.S. Veterans Receiving Regimens Containing Tenofovir Disoproxil Fumarate/Emtricitabine
por: Nelson, Richard E., et al.
Publicado: (2018) -
Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004–2009
por: Gundlapalli, Adi V., et al.
Publicado: (2015) -
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals
por: LaFleur, Joanne, et al.
Publicado: (2018) -
Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)